<!DOCTYPE html>
<html lang="en">
<head>
     <meta charset="UTF-8">
     <title>2015 Progress and Controversies in Gynecologic Oncology Conference</title>
</head>
<body>
  <table width="100%" cellpadding="0" cellspacing="0">
  <tr>
  <td align="center">
    <table width="600" cellspacing="0" cellpadding="0" border="0">
<!-- header -->
    <tr>
      <td align="center">
        <p style="font-family:Arial;font-size:12px;font-weight:normal;color:#4c4c4c;vertical-align:middle; margin-bottom: 10px;">
          <img src="https://i1.createsend1.com/ei/d/B7/A7A/B9C/024117/csimport/prime_0.png" alt="prIME Oncology" border="0" style="vertical-align:middle; margin-right: 12px; margin-bottom:15px" />professional • independent • medical • education
        </p>
      </td>
    </tr>
          <tr>
      <td><img src="http://www.primeoncology.org/online_education/solid_tumor/2015/~/media/Images/Activity/2015/gyn_con/GYN-CONGRESS-2015_Banner-v2_997x157.ashx?w=936" width="610" border="0" style="display:block;" alt="2015 Progress and Controversies in Gynecologic Oncology Conference"/></td>
    </tr>
    
<!-- content -->
      <tr>
        <td style="border-right:solid #666 7px; border-left:solid #666 7px;" align="center">
 
 
                <!-- Inner Content Table -->
           <table cellspacing="0" width="580" style="border: 20px solid #fff; table-layout: fixed;" border="0">
            <tr>
              <td>
                <h2 style="font-family:Arial;font-size:16px;font-weight:bold;color:#ff6600;margin:0; padding: 0;display:inline;">2015 Progress and Controversies in Gynecologic Oncology Conference</h2>
                <br>
               
                <span style="font-family: Arial;font-size: 12px;font-weight: normal;color: #4c4c4c;">This Webcast contains <strong>video and downloadable slides</strong> from the meeting <em>2015 Progress and Controversies in Gynecologic Oncology Conference</em>, a prIME Oncology educational activity that was held on 16-17 January 2015, in Barcelona, Spain.</span><br>
                <br>
              
                <p style="font-size: 14px; font-family: arial,helvetica,sans-serif;
                 color: #4c4c4c; width: 150px;">&raquo;<a href="http://www.primeoncology.org/online_education/solid_tumor/2015/webcast-gynconference2015.aspx" style="text-decoration:none;" target="_blank"> <strong>View Activity</strong></a></p>
              
                 <p style="font-family:Arial;font-size:12px;font-weight:normal;color:#ccc; text-align:center;">
                 ___________________________________________________________</p>
              
                <h2 style="font-family:Arial;font-size:16px;font-weight:bold;color:#ff6600;margin-bottom:15px">Activity Features</h2>
              
                <table cellspacing="0" cellpadding="0" border="0" width="100%">
                  <tr>
                    <td valign="top">
                      <table cellpadding="0" cellspacing="6" border="0">
                        <tr>
                          <td><img src="http://www.primeoncology.org/Presentation/Onco/assets/images/icons/Presentation.png" alt="icon" width="32" height="32" border="0"></td>
                          <td><h5 style="font-family:Arial, Helvetica, sans-serif;color:#666; padding: 0;margin: 0;font-size:12px;display: inline-block;height: 22px;vertical-align: middle;">Interactive Presentation</h5></td>
                        </tr>
                        <tr>
                          <td><img src="http://www.primeoncology.org/Presentation/Onco/assets/images/icons/Download.png" alt="icon" width="32" height="32" border="0"></td>
                          <td><h5 style="font-family:Arial, Helvetica, sans-serif;color:#666; padding: 0;margin: 0;font-size:12px;display: inline-block;height: 22px;vertical-align: middle;">Downloadable Slides</h5></td>
                        </tr>
                      </table>
                    </td>
                    <td colspan="2" align="center">
                      <img src="http://www.primeoncology.org/online_education/solid_tumor/2015/~/media/Images/Activity/2015/gyn_con/Landing_Image.ashx" alt="preview" width="330" height="230" border="0" style="border-style:none;">
                    </td>
                  </tr>
                </table>
                
                  
                <p style="font-family:Arial;font-size:12px;font-weight:normal;color:#ccc; text-align:center;">
                  ___________________________________________________________</p>

                <h2 style="font-family:Arial;font-size:16px;font-weight:bold;color:#ff6600;margin-bottom:15px">Topics</h2>

                <h2 style="font-family:Arial;font-size:13px;font-weight:bold;color:#ff6600;margin-bottom:5px">Session I—Cervical Cancer and Vulvar Cancer</h2>

                <p style="font-family: Arial;font-size: 12px;font-weight: normal;color: #4c4c4c;">Current status of treatment for vulvar cancer <br>
                <em>Sven Mahner, MD, PhD</em></p>

                <p style="font-family: Arial;font-size: 12px;font-weight: normal;color: #4c4c4c;">Technical innovations in robotic surgery <br>
                <em>Jan Persson, MD, PhD</em></p>

                <p style="font-family: Arial;font-size: 12px;font-weight: normal;color: #4c4c4c;">Update on neoadjuvant chemotherapy in cervical cancer <br>
                <em>Nicoletta Colombo, MD</em></p>

                <p style="font-family: Arial;font-size: 12px;font-weight: normal;color: #4c4c4c;">Update on targeted therapy and immunotherapy for cervical cancer <br>
                <em>Bradley J. Monk, MD, FACS, FACOG</em></p>

                <h2 style="font-family:Arial;font-size:13px;font-weight:bold;color:#ff6600;margin-bottom:5px">Session II—Endometrial Cancer and Beyond</h2>
                <p style="font-family: Arial;font-size: 12px;font-weight: normal;color: #4c4c4c;">
                Debate: Role of radiotherapy in grade 3 FIGO IB endometrial cancer – Pro<br>
                <em>Alexandra Taylor, MBBS, MD</em></p>
                 <p style="font-family: Arial;font-size: 12px;font-weight: normal;color: #4c4c4c;">
                Debate: Role of radiotherapy in grade 3 FIGO IB endometrial cancer - Contra<br>
                <em>Mansoor R. Mirza, MD</em></p>
                <p style="font-family: Arial;font-size: 12px;font-weight: normal;color: #4c4c4c;">
                Treatment of recurrent endometrial cancer and evaluation of new agents<br>
                <em>Andrés Poveda, MD</em></p>
                <p style="font-family: Arial;font-size: 12px;font-weight: normal;color: #4c4c4c;">
                 What are the oncologic risks of morcellation of the uterus? <br>
                <em>Frédéric Amant, MD, PhD</em></p>
               

                <h2 style="font-family:Arial;font-size:13px;font-weight:bold;color:#ff6600;margin-bottom:5px">Session III—Ovarian Neoplasm I: Emerging Concepts </h2>
                 <p style="font-family: Arial;font-size: 12px;font-weight: normal;color: #4c4c4c;">
                  The impact of molecular testing on therapeutic decisions in ovarian cancer<br>
                <em>Michael Birrer, MD, PhD</em></p>
                <p style="font-family: Arial;font-size: 12px;font-weight: normal;color: #4c4c4c;">
                 Evolving role of upfront and postoperative imaging in ovarian cancer <br>
                <em>Vincent Vandecaveye, MD, PhD</em></p>
                <p style="font-family: Arial;font-size: 12px;font-weight: normal;color: #4c4c4c;">
                  Future of targeted agents and combinations in ovarian cancer<br>
                <em>Stanley B. Kaye, MD</em></p>

                <h2 style="font-family:Arial;font-size:13px;font-weight:bold;color:#ff6600;margin-bottom:5px">Session IV—Ovarian Neoplasm II: Practical Applications in the First-Line Setting</h2>
                <p style="font-family: Arial;font-size: 12px;font-weight: normal;color: #4c4c4c;">
                  Personalized medicine: Identification and treatment of fragile patients<br>
                <em>Felix Hilpert, MD, DMSci</em></p>
                <p style="font-family: Arial;font-size: 12px;font-weight: normal;color: #4c4c4c;">
                  Debate: HIPEC plays a role in treatment of advanced ovarian cancer - Pro<br>
                <em>Anna Fagotti, MD, PhD</em></p>
                <p style="font-family: Arial;font-size: 12px;font-weight: normal;color: #4c4c4c;">
                  Debate: HIPEC plays a role in treatment of advanced ovarian cancer - Contra<br>
                <em>Philipp Harter, MD</em></p>

                <h2 style="font-family:Arial;font-size:13px;font-weight:bold;color:#ff6600;margin-bottom:5px">Session V—Borderline Ovarian Tumors</h2>
                <p style="font-family: Arial;font-size: 12px;font-weight: normal;color: #4c4c4c;">
                  Pathologist’s view on the current status of borderline tumors<br>
                <em>Jaime Prat, MD, PhD, FRCPath </em></p>
                <p style="font-family: Arial;font-size: 12px;font-weight: normal;color: #4c4c4c;">
                  Clinical aspects: Fertility-sparing surgery of borderline ovarian tumors<br>
                <em>Philippe Morice, MD</em></p>

                <h2 style="font-family:Arial;font-size:13px;font-weight:bold;color:#ff6600;margin-bottom:5px">Session VI—Ovarian Neoplasm III: Recurrence</h2>
                <p style="font-family: Arial;font-size: 12px;font-weight: normal;color: #4c4c4c;">
                  Interactive Clinical Case: Platinum-resistant disease<br>
                <em>Ignace Vergote, MD, PhD</em></p>
                <p style="font-family: Arial;font-size: 12px;font-weight: normal;color: #4c4c4c;">
                  Interactive Clinical Case: Platinum-sensitive disease <br>
                <em>Andreas du Bois, MD, PhD</em></p>
                 <p style="font-family: Arial;font-size: 12px;font-weight: normal;color: #4c4c4c;">
                 Ovarian cancer patients who have received multiple prior therapies: When to stop or continue treatment?  <br>
                <em>Eric Pujade-Lauraine, MD, PhD</em></p>

                <p style="font-family:Arial;font-size:12px;font-weight:normal;color:#ccc; text-align:center;">
                     ___________________________________________________________</p>
                    
                <h2 style="font-family:Arial;font-size:16px;font-weight:bold;color:#ff6600;margin-bottom:15px;">Faculty</h2>
                <h2 style="font-family:Arial;font-size:14px;font-weight:bold;margin-bottom:5px;color: #4c4c4c;">Co-Chairs</h2>
                <p style="font-family: Arial;font-size: 12px;font-weight: normal;color: #4c4c4c;">
                  <table cellpadding="0" cellspacing="0">
                    <tr>
                      <td width="250">
                        <p style="font-family: Arial;font-size: 12px;font-weight: normal;color: #4c4c4c;">
                        <strong>Andreas du Bois, MD, PhD</strong> <br>
                            Kliniken Essen-Mitte <br>
                            Essen, Germany <br><br></p>
                      </td>
                      <td>
                        <p style="font-family: Arial;font-size: 12px;font-weight: normal;color: #4c4c4c;">
                         <strong>Ignace Vergote, MD, PhD</strong> <br>
                          University Hospital Gasthuisberg <br>
                          Leuven, Belgium <br><br></p>
                      </td>
                    </tr>
                    <tr>
                      <td>
                        <p style="font-family: Arial;font-size: 12px;font-weight: normal;color: #4c4c4c;">
                         <strong>Stanley B. Kaye, MD</strong> <br>
                          The Royal Marsden Hospital <br>
                          Sutton, United Kingdom <br><br>
                        </p>
                      </td>
                    </tr>
                  </table>
                   

                   

                   
                </p>
                <h2 style="font-family:Arial;font-size:14px;font-weight:bold;margin-bottom:5px;color: #4c4c4c;">Scientific Committee</h2>
                <p style="font-family: Arial;font-size: 12px;font-weight: normal;color: #4c4c4c;">
                  <table cellpadding="0" cellspacing="0">
                    <tr>
                      <td width="250">
                        <p style="font-family: Arial;font-size: 12px;font-weight: normal;color: #4c4c4c;">
                        <strong>Nicoletta Colombo, MD</strong> <br>
                        University of Milan-Bicocca <br>
                        Milan, Italy<br><br>

                        <strong>Andrés Poveda, MD</strong> <br>
                        Fundaci&#243;n Instituto Valenciano <br>de Oncología <br>
                        Valencia, Spain
                      </p>
                      </td>
                      <td width="250">
                        <p style="font-family: Arial;font-size: 12px;font-weight: normal;color: #4c4c4c;">
                        <strong>Bradley J. Monk, MD, FACS, FACOG</strong> <br>
                        Creighton University School of Medicine <br>
                        St Joseph's Hospital and Medical Center <br>
                        Phoenix, Arizona, United States <br><br>

                        <strong>Eric Pujade-Lauraine, MD, PhD</strong> <br>
                        Centre Hospitalier Universitaire Hôtel-Dieu <br>
                        Paris, France</p>
                      </td>
                    </tr>
                  </table>


                </p>
                <h2 style="font-family:Arial;font-size:14px;font-weight:bold;margin-bottom:5px;color: #4c4c4c;">Faculty</h2>
                  <p style="font-family: Arial;font-size: 12px;font-weight: normal;color: #4c4c4c;">
                  <table cellpadding="0" cellspacing="0">
                    <tr>
                      <td width="250">
                        <p style="font-family: Arial;font-size: 12px;font-weight: normal;color: #4c4c4c;">
                        <strong>Frédéric Amant, MD, PhD</strong> <br>
                        Catholic University <br>
                        Leuven, Belgium <br><br>

                        <strong>Anna Fagotti, MD, PhD</strong> <br>
                        Catholic University of the Sacred Heart <br>
                        Rome, Italy <br><br>

                        <strong>Felix Hilpert, MD, DMSci</strong> <br>
                        Christian-Albrechts-University of Kiel <br>
                        Kiel, Germany <br><br>

                        <strong>Mansoor Mirza, MD</strong> <br>
                        Rigshospitalet <br>
                        Copenhagen, Denmark <br><br>

                        <strong>Jan Persson, MD, PhD</strong> <br>
                        Lund University <br>
                        Lund, Sweden <br><br>

                        <strong>Alexandra Taylor, MBBS, MD</strong> <br>
                        The Royal Marsden Hospital <br>
                        London, United Kingdom <br><br>
                        </p>
                      </td>
                      <td  width="250">
                        <p style="font-family: Arial;font-size: 12px;font-weight: normal;color: #4c4c4c;">
                        <strong>Michael Birrer, MD, PhD</strong> <br>
                        Massachusetts General Hospital <br>
                        Boston, Massachusetts, United States <br><br>

                        <strong>Philipp Harter, MD</strong> <br>
                        Kliniken Essen-Mitte <br>
                        Essen, Germany <br><br>

                        <strong>Sven Mahner, MD, PhD</strong> <br>
                        University Medical Center Hamburg-Eppendorf <br>
                        Hamburg, Germany <br><br>

                        <strong>Philippe Morice, MD</strong> <br>
                        Institute Gustave Roussy <br>
                        Villejuif, France <br><br>

                        <strong>Jaime Prat, MD, PhD, FRCPath</strong> <br>
                        Hospital de la Santa Creu i Sant Pau <br>
                        Barcelona, Spain <br><br>

                        <strong>Vincent Vandecaveye, MD, PhD</strong> <br>
                        University of Leuven <br>
                        Leuven, Belgium <br>
                        </p>
                      </td>
                    </tr>
                  </table>
                 </p>
                
                <p style="font-size: 14px; font-family: arial,helvetica,sans-serif;
                 color: #4c4c4c; width: 150px;">&raquo;<a href="http://www.primeoncology.org/online_education/solid_tumor/2015/webcast-gynconference2015.aspx" style="text-decoration:none;" target="_blank"> <strong>View Activity</strong></a></p>
              
              
                <p style="font-family:Arial;font-size:12px;font-weight:normal;color:#ccc; text-align:center;">
                 ___________________________________________________________</p>
              
              
                <h2 style="font-family:Arial;font-size:16px;font-weight:bold;color:#ff6600;margin-bottom:15px">Provider</h2>
              
                <p style="font-family: Arial;font-size: 12px;font-weight: normal;color: #4c4c4c;">This activity is provided by prIME Oncology.</p>

                <div align="center"><img src="http://www.primeoncology.org/live_education/heme/~/media/Images/Sponsor/prime.ashx" alt="ACCME" width="112" height="66" /></div>
              
                <p style="font-family:Arial;font-size:12px;font-weight:normal;color:#ccc; text-align:center;">
                  ___________________________________________________________</p>
                 
                 
                <h2 style="font-family:Arial;font-size:16px;font-weight:bold;color:#ff6600;margin-bottom:10px">Support</h2>
                  
                <p colspan="3" style="font-family: Arial;font-size: 12px;font-weight: normal;color: #4c4c4c;">This educational activity is supported by AstraZeneca and F. Hoffmann-La Roche Ltd.<br>
                  
                </p>
                 <p style="font-family:Arial;font-size:12px;font-weight:normal;color:#ccc; text-align:center;">
                 ___________________________________________________________</p>
                 
                <h2 style="font-family:Arial;font-size:16px;font-weight:bold;color:#ff6600;margin-bottom:10px">Other Recent prIME Activities</h2>
                  
                <table cellpadding="0" cellspacing="5" border="0" align="center">
                  <tr valign="top">
                    <td align="center">
                      <a style="font-family: Arial;font-size: 12px;font-weight: normal;color: #4C4C4C; text-decoration:none" href="http://www.primeoncology.org/online_education/solid_tumor/2015/dinnersymposium_barcelona_2015_webcast.aspx">
                      <img src="http://www.primeoncology.org/~/media/Images/Activity/2015/gyn%20dinner/thumb.ashx" alt="online activity" style="border-style:none" /><br/>
                     Integrating New Therapies Into Ovarian Cancer Management: Does BRCA Status Matter
                      </a>
                    </td>
                    
                    <td align="center">
                      <a style="font-family: Arial;font-size: 12px;font-weight: normal;color: #4C4C4C; text-decoration:none" href="http://www.primeoncology.org/online_education/solid_tumor/2015/lunchsymposium_barcelona_2015_webcast.aspx">
                      <img src="http://www.primeoncology.org/~/media/Images/Activity/2015/gyn-lunch/PB5LSS012_Fine-Tuning%20the%20Management%20of%20Advanced%20Ovarian%20and%20Cervical%20Thumbnail.ashx" alt="online activity" style="border-style:none" /><br/>
                      Fine-Tuning the Management of Advanced Ovarian and Cervical Cancer: Aligning Opinion With the Experts</a>
                    </td>
                  </tr>
                </table>
                <h2 style="font-family:Arial;font-size:16px;font-weight:bold;color:#ff6600;margin-bottom:10px">Future Activities of Interest</h2>
                  
                <table cellpadding="0" cellspacing="10" border="0" align="center">
                  <tr valign="top">
                    <td align="center" width="200">
                      <a style="font-family: Arial;font-size: 12px;font-weight: normal;color: #4C4C4C; text-decoration:none; text-align: center;" href="www.prIMEoncology.org/EPGyn_Brussels2015">
                      <img src=" http://www.primeoncology.org/~/media/Images/Activity/2016/ep-gyn/thumb.ashx" alt="online activity" style="border-style:none" /><br/>
                      
                      EP Gyn Meeting <br> 25 April Brussels
                      </a>
                    </td>
                    <td>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</td>
                    <td align="center">
                      <img src="http://www.primeoncology.org/~/media/Images/Activity/2016/gyn-webcast/thumb.ashx" alt="online activity" style="border-style:none" /><br/>
                      <span style="font-family: Arial;font-size: 12px;font-weight: normal;color: #4C4C4C; text-decoration:none">
                      Save-The-Date <br>  More information coming soon</span>
                    </td>
                  </tr>
                </table>
              </td>
            </tr>
           </table><!-- //Inner Content Table -->
     
 
        </td>
      </tr>
<!--       footer -->
      <tr style="background-color: #666666;">
        <td>
          <table width="100%" style="border-right:solid #666 7px; border-left:solid #666 7px;border-bottom:solid #666 7px;" border="0">
            <tr>
              <td align="center">
                <table cellpadding="0" cellspacing="0" style="color: #fff; padding: 30px 10px 10px 30px; font-family:Arial, Helvetica, sans-serif;font-size: 12px; font-weight: normal;" border="0">
                  <tr valign="top">
                    <td style="padding-right: 6px;" align="right">
                       <img src="http://www.primeoncology.org/~/media/Images/Image%20Links/mobile.ashx" alt="icon" width="32" height="32" border="0" />
                    </td>
                    <td style="padding-bottom: 15px;">
                       <strong>Get the prIME Oncology app</strong><br />
                       <a style="color: #fd8332; text-decoration: none; font-weight: bold;" href="https://itunes.apple.com/us/app/prime-oncology/id681001525?ls=1&mt=8">iPhone</a>
                       <span> | </span>
                       <a style="color: #fd8332; text-decoration: none; font-weight: bold;" href="https://play.google.com/store/apps/details?id=com.primeoncology.mobile&hl=en">Android</a>
                    </td>
                  </tr>
                </table>
              </td>
              <td align="center">
                <a style="padding-left: 10px;" href="https://plus.google.com/109069474896753641435"><img alt='google' src="http://www.primeoncology.org/~/media/Images/Image%20Links/google.ashx" /></a>
                <a style="padding-left: 10px;" href="https://twitter.com/prIME_Oncology"><img alt='twitter' src="http://www.primeoncology.org/~/media/Images/Image%20Links/twitter.ashx" /></a>
                <a style="padding-left: 10px;" href="http://www.youtube.com/user/prIMEOncologyUpdate"><img alt='youtube' src="http://www.primeoncology.org/~/media/Images/Image%20Links/youtube.ashx" /></a>
                <a style="padding-left: 10px;" href="http://www.facebook.com/pages/Prime-Oncology/364934120249753"><img alt='facebook' src="http://www.primeoncology.org/~/media/Images/Image%20Links/facebook.ashx" /></a>
                <a style="padding-left: 10px;" href="http://www.linkedin.com/company/prime-oncology/"><img alt='linkedin' src="http://www.primeoncology.org/~/media/Images/Image%20Links/linkedin.ashx" /></a></td>
            </tr>
            
            <tr>
              <td colspan="2" align="center">
                <table width="100%">
                  <tr>
                    <td width="36%" align="right">
                      <img hspace="15" src="http://primehc.org/email/images/logos/prime.png" alt="prIME Oncology" width="45" height="27" style="vertical-align: top;" border="0">
                    </td>
                    <td width="64%">
                      <p style="font-size: 10px;color: #bbb;font-family: Arial; text-align:left;">
                      Schenkkade 50 | Suite 16 | 2595 AR The Hague | the Netherlands
                      </p>
                    </td>
                  </tr>
                </table>
              </td>
            </tr>
          </table>
        </td>
      </tr>
    </table>
  </td></tr></table>
</body>
</html>



​